Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

10x Genomics (TXG) Return on Sales (2018 - 2025)

10x Genomics' Return on Sales history spans 8 years, with the latest figure at 0.1% for Q4 2025.

  • For Q4 2025, Return on Sales rose 20.0% year-over-year to 0.1%; the TTM value through Dec 2025 reached 0.07%, up 23.0%, while the annual FY2025 figure was 0.07%, 23.0% up from the prior year.
  • Return on Sales for Q4 2025 was 0.1% at 10x Genomics, up from 0.18% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.2% in Q2 2025 and bottomed at 0.61% in Q3 2023.
  • The 5-year median for Return on Sales is 0.24% (2024), against an average of 0.25%.
  • The largest annual shift saw Return on Sales soared 357bps in 2021 before it plummeted -47bps in 2022.
  • A 5-year view of Return on Sales shows it stood at 0.13% in 2021, then grew by 14bps to 0.11% in 2022, then plummeted by -141bps to 0.27% in 2023, then dropped by -12bps to 0.3% in 2024, then skyrocketed by 67bps to 0.1% in 2025.
  • Per Business Quant, the three most recent readings for TXG's Return on Sales are 0.1% (Q4 2025), 0.18% (Q3 2025), and 0.2% (Q2 2025).